McGuire+WL - Search Results

1

What do we know about health care team effectiveness? A review of the literature.

Lemieux-Charles L, McGuire WL. Lemieux-Charles L, et al. Med Care Res Rev. 2006 Jun;63(3):263-300. doi: 10.1177/1077558706287003. Med Care Res Rev. 2006. PMID: 16651394 Review.

2

Beyond EBM: new directions for evidence-based public health.

McGuire WL. McGuire WL. Perspect Biol Med. 2005 Autumn;48(4):557-69. doi: 10.1353/pbm.2005.0081. Perspect Biol Med. 2005. PMID: 16227667

3

Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review.

Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA. Ciocca DR, et al. J Natl Cancer Inst. 1993 Oct 6;85(19):1558-70. doi: 10.1093/jnci/85.19.1558. J Natl Cancer Inst. 1993. PMID: 8411230 Review.

4

DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.

Wenger CR, Beardslee S, Owens MA, Pounds G, Oldaker T, Vendely P, Pandian MR, Harrington D, Clark GM, McGuire WL. Wenger CR, et al. Breast Cancer Res Treat. 1993 Oct;28(1):9-20. doi: 10.1007/BF00666351. Breast Cancer Res Treat. 1993. PMID: 8123871

5

Glutathione transferase GST pi in breast tumors evaluated by three techniques.

Molina R, Oesterreich S, Zhou JL, Tandon AK, Clark GM, Allred DC, Townsend AJ, Moscow JA, Cowan KH, McGuire WL, et al. Molina R, et al. Dis Markers. 1993 Sep;11(2-3):71-82. doi: 10.1155/1993/906187. Dis Markers. 1993. PMID: 8261735

6

Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.

Papa V, Gliozzo B, Clark GM, McGuire WL, Moore D, Fujita-Yamaguchi Y, Vigneri R, Goldfine ID, Pezzino V. Papa V, et al. Cancer Res. 1993 Aug 15;53(16):3736-40. Cancer Res. 1993. PMID: 8339284

7

Citation for the Rhône-Poulenc Rorer Clinical Investigator Lecture Award of The Endocrine Society to William L. McGuire.

[No authors listed] [No authors listed] Mol Endocrinol. 1993 Aug;7(8):1091-2. doi: 10.1210/mend.7.8.8232309. Mol Endocrinol. 1993. PMID: 8232309 No abstract available.

8

Citation for the Rhône-Poulenc Rorer Clinical Investigator Lecture Award of the Endocrine Society to William L. McGuire.

[No authors listed] [No authors listed] Endocr Rev. 1993 Aug;14(4):499-500. Endocr Rev. 1993. PMID: 8223345 No abstract available.

9

The 28-kDa protein whose phosphorylation is induced by protein kinase C activators in MCF-7 cells belongs to the family of low molecular mass heat shock proteins and is the estrogen-regulated 24-kDa protein.

Faucher C, Capdevielle J, Canal I, Ferrara P, Mazarguil H, McGuire WL, Darbon JM. Faucher C, et al. J Biol Chem. 1993 Jul 15;268(20):15168-73. J Biol Chem. 1993. PMID: 8325890 Free article.

10

Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status.

Figueroa JA, Jackson JG, McGuire WL, Krywicki RF, Yee D. Figueroa JA, et al. J Cell Biochem. 1993 Jun;52(2):196-205. doi: 10.1002/jcb.240520211. J Cell Biochem. 1993. PMID: 7690042

11

Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients.

Elledge RM, Ciocca DR, Langone G, McGuire WL. Elledge RM, et al. Cancer. 1993 Apr 15;71(8):2499-506. doi: 10.1002/1097-0142(19930415)71:8<2499::aid-cncr2820710812>3.0.co;2-s. Cancer. 1993. PMID: 8095853

12

Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications.

Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL. Ciocca DR, et al. J Natl Cancer Inst. 1993 Apr 7;85(7):570-4. doi: 10.1093/jnci/85.7.570. J Natl Cancer Inst. 1993. PMID: 8455204

13

How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer.

Clark GM, Wenger CR, Beardslee S, Owens MA, Pounds G, Oldaker T, Vendely P, Pandian MR, Harrington D, McGuire WL. Clark GM, et al. Cancer. 1993 Mar 15;71(6 Suppl):2157-62. doi: 10.1002/1097-0142(19930315)71:6+<2157::aid-cncr2820711606>3.0.co;2-o. Cancer. 1993. PMID: 8443766

14

Prognostic indicators in early breast cancer.

Figueroa JA, Yee D, McGuire WL. Figueroa JA, et al. Am J Med Sci. 1993 Mar;305(3):176-82. doi: 10.1097/00000441-199303000-00010. Am J Med Sci. 1993. PMID: 7680528 Review.

15

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.

Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL. Allred DC, et al. J Natl Cancer Inst. 1993 Feb 3;85(3):200-6. doi: 10.1093/jnci/85.3.200. J Natl Cancer Inst. 1993. PMID: 8423624

16

Estrogen receptor mutations in breast cancer.

Fuqua SA, Chamness GC, McGuire WL. Fuqua SA, et al. J Cell Biochem. 1993 Feb;51(2):135-9. doi: 10.1002/jcb.240510204. J Cell Biochem. 1993. PMID: 8440747 Review.

17

Prognosis of breast cancer patients: how to use what?

Clark GM, McGuire WL. Clark GM, et al. Recent Results Cancer Res. 1993;127:55-60. doi: 10.1007/978-3-642-84745-5_8. Recent Results Cancer Res. 1993. PMID: 8502830 Review. No abstract available.

18

Prognostic factors and therapeutic decisions in axillary node-negative breast cancer.

Elledge RM, McGuire WL. Elledge RM, et al. Annu Rev Med. 1993;44:201-10. doi: 10.1146/annurev.me.44.020193.001221. Annu Rev Med. 1993. PMID: 8476242 Review.

19

Neural Network Analysis of DNA flow cytometry histograms.

Ravdin PM, Clark GM, Hough JJ, Owens MA, McGuire WL. Ravdin PM, et al. Cytometry. 1993;14(1):74-80. doi: 10.1002/cyto.990140113. Cytometry. 1993. PMID: 8432206 Free article.

20

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.

Encarnación CA, Ciocca DR, McGuire WL, Clark GM, Fuqua SA, Osborne CK. Encarnación CA, et al. Breast Cancer Res Treat. 1993;26(3):237-46. doi: 10.1007/BF00665801. Breast Cancer Res Treat. 1993. PMID: 8251648

21

Prognostic significance of p53 gene alterations in node-negative breast cancer.

Elledge RM, Fuqua SA, Clark GM, Pujol P, Allred DC, McGuire WL. Elledge RM, et al. Breast Cancer Res Treat. 1993;26(3):225-35. doi: 10.1007/BF00665800. Breast Cancer Res Treat. 1993. PMID: 8251647

22

The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.

Fuqua SA, Allred DC, Elledge RM, Krieg SL, Benedix MG, Nawaz Z, O'Malley BW, Greene GL, McGuire WL. Fuqua SA, et al. Breast Cancer Res Treat. 1993;26(2):191-202. doi: 10.1007/BF00689692. Breast Cancer Res Treat. 1993. PMID: 8219256

23

Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques.

Molina R, Ciocca DR, Tandon AK, Allred DC, Clark GM, Chamness GC, Gullick WJ, McGuire WL. Molina R, et al. Anticancer Res. 1992 Nov-Dec;12(6B):1965-71. Anticancer Res. 1992. PMID: 1363511

24

Prognosis and treatment decisions in patients with breast cancer without axillary node involvement.

McGuire WL, Tandon AK, Allred DC, Chamness GC, Ravdin PM, Clark GM. McGuire WL, et al. Cancer. 1992 Sep 15;70(6 Suppl):1775-81. doi: 10.1002/1097-0142(19920915)70:4+<1775::aid-cncr2820701619>3.0.co;2-8. Cancer. 1992. PMID: 1355403

25

Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.

McGuire WL Jr, Jackson JG, Figueroa JA, Shimasaki S, Powell DR, Yee D. McGuire WL Jr, et al. J Natl Cancer Inst. 1992 Sep 2;84(17):1336-41. doi: 10.1093/jnci/84.17.1336. J Natl Cancer Inst. 1992. PMID: 1379645

26

Abnormal estrogen receptor in clinical breast cancer.

McGuire WL, Chamness GC, Fuqua SA. McGuire WL, et al. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):243-7. doi: 10.1016/0960-0760(92)90214-4. J Steroid Biochem Mol Biol. 1992. PMID: 1525064 Review.

27

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.

Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL. Allred DC, et al. Hum Pathol. 1992 Sep;23(9):974-9. doi: 10.1016/0046-8177(92)90257-4. Hum Pathol. 1992. PMID: 1355464

28

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.

Ravdin PM, Green S, Dorr TM, McGuire WL, Fabian C, Pugh RP, Carter RD, Rivkin SE, Borst JR, Belt RJ, et al. Ravdin PM, et al. J Clin Oncol. 1992 Aug;10(8):1284-91. doi: 10.1200/JCO.1992.10.8.1284. J Clin Oncol. 1992. PMID: 1634918

29

Uptake of the noncytotoxic transport probe procainamide in the Chinese hamster ovary model of multidrug resistance.

Speeg KV Jr, deLeon C, McGuire WL. Speeg KV Jr, et al. Cancer Res. 1992 Jul 1;52(13):3539-46. Cancer Res. 1992. PMID: 1617623

30

Response of human breast cancer cells to heat shock and chemotherapeutic drugs.

Ciocca DR, Fuqua SA, Lock-Lim S, Toft DO, Welch WJ, McGuire WL. Ciocca DR, et al. Cancer Res. 1992 Jul 1;52(13):3648-54. Cancer Res. 1992. PMID: 1617638

31

Prognostic factors and treatment decisions in axillary-node-negative breast cancer.

McGuire WL, Clark GM. McGuire WL, et al. N Engl J Med. 1992 Jun 25;326(26):1756-61. doi: 10.1056/NEJM199206253262607. N Engl J Med. 1992. PMID: 1594018 Review. No abstract available.

32

Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors.

Wiebe VJ, Osborne CK, McGuire WL, DeGregorio MW. Wiebe VJ, et al. J Clin Oncol. 1992 Jun;10(6):990-4. doi: 10.1200/JCO.1992.10.6.990. J Clin Oncol. 1992. PMID: 1588380

33

Prognostic factors in breast cancer.

Elledge RM, McGuire WL, Osborne CK. Elledge RM, et al. Semin Oncol. 1992 Jun;19(3):244-53. Semin Oncol. 1992. PMID: 1351692 Review. No abstract available.

34

Optimal mastectomy timing.

McGuire WL, Hilsenbeck S, Clark GM. McGuire WL, et al. J Natl Cancer Inst. 1992 Mar 4;84(5):346-8. doi: 10.1093/jnci/84.5.346. J Natl Cancer Inst. 1992. PMID: 1738187 No abstract available.

35

Progesterone antagonists: tumor-inhibiting potential and mechanism of action.

Michna H, Nishino Y, Neef G, McGuire WL, Schneider MR. Michna H, et al. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):339-48. doi: 10.1016/0960-0760(92)90360-u. J Steroid Biochem Mol Biol. 1992. PMID: 1562510 Review.

36

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients.

Osborne CK, Wiebe VJ, McGuire WL, Ciocca DR, DeGregorio MW. Osborne CK, et al. J Clin Oncol. 1992 Feb;10(2):304-10. doi: 10.1200/JCO.1992.10.2.304. J Clin Oncol. 1992. PMID: 1732430

37

Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors.

Fuqua SA, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL, McGuire WL. Fuqua SA, et al. Cancer Res. 1992 Jan 15;52(2):483-6. Cancer Res. 1992. PMID: 1728420

38

Treatment decisions in axillary node-negative breast cancer patients.

McGuire WL, Tandon AK, Allred DC, Chamness GC, Ravdin PM, Clark GM. McGuire WL, et al. J Natl Cancer Inst Monogr. 1992;(11):173-80. J Natl Cancer Inst Monogr. 1992. PMID: 1627425 Clinical Trial.

39

Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076).

Dressler LG, Eudey L, Gray R, Tormey DC, McGuire WL, Gilchrist KW, Clark GM, Osborne CK, Mansour EG, Abeloff MD. Dressler LG, et al. J Natl Cancer Inst Monogr. 1992;(11):167-72. J Natl Cancer Inst Monogr. 1992. PMID: 1627424 Clinical Trial.

40

Abnormal oestrogen receptor in clinical breast cancer.

McGuire WL, Chamness GC, Fuqua SA. McGuire WL, et al. Eur J Cancer. 1992;28(2-3):309-10. doi: 10.1016/s0959-8049(05)80040-1. Eur J Cancer. 1992. PMID: 1591044 Review. No abstract available.

41

In memoriam--William L. McGuire.

[No authors listed] [No authors listed] Breast Cancer Res Treat. 1992;23(1-2):7-15. doi: 10.1007/BF01831471. Breast Cancer Res Treat. 1992. PMID: 1446054 No abstract available.

42

The importance of normal and abnormal oestrogen receptor in breast cancer.

McGuire WL, Chamness GC, Fuqua SA. McGuire WL, et al. Cancer Surv. 1992;14:31-40. Cancer Surv. 1992. PMID: 1423328 Review.

43

Why do so many prognostic factors fail to pan out?

Hilsenbeck SG, Clark GM, McGuire WL. Hilsenbeck SG, et al. Breast Cancer Res Treat. 1992;22(3):197-206. doi: 10.1007/BF01840833. Breast Cancer Res Treat. 1992. PMID: 1391986

44

A demonstration that breast cancer recurrence can be predicted by neural network analysis.

Ravdin PM, Clark GM, Hilsenbeck SG, Owens MA, Vendely P, Pandian MR, McGuire WL. Ravdin PM, et al. Breast Cancer Res Treat. 1992;21(1):47-53. doi: 10.1007/BF01811963. Breast Cancer Res Treat. 1992. PMID: 1391974

45

Volume dedicated to the memory and achievements of Professor William L. McGuire, M.D.

[No authors listed] [No authors listed] Cancer Treat Res. 1992;63:1-382. Cancer Treat Res. 1992. PMID: 1363352 No abstract available.

46

Prognostic factors in axillary node-negative breast cancer.

Elledge RM, McGuire WL. Elledge RM, et al. Cancer Treat Res. 1992;61:3-19. doi: 10.1007/978-1-4615-3500-3_1. Cancer Treat Res. 1992. PMID: 1360238 Review. No abstract available.

47

Genes, oncogenes, and hormones. Dedicated to William L. McGuire.

[No authors listed] [No authors listed] Cancer Treat Res. 1992;61:1-431. Cancer Treat Res. 1992. PMID: 1360228 No abstract available.

48

Defining the high-risk breast cancer patient.

Clark GM, McGuire WL. Clark GM, et al. Cancer Treat Res. 1992;60:161-87. doi: 10.1007/978-1-4615-3496-9_7. Cancer Treat Res. 1992. PMID: 1355985 Review. No abstract available.

49

Estrogen receptor variants in clinical breast cancer.

McGuire WL, Chamness GC, Fuqua SA. McGuire WL, et al. Mol Endocrinol. 1991 Nov;5(11):1571-7. doi: 10.1210/mend-5-11-1571. Mol Endocrinol. 1991. PMID: 1779964 Review.

50

Estrogen receptor determination and long term survival of patients with carcinoma of the breast.

Crowe JP Jr, Gordon NH, Hubay CA, Shenk RR, Zollinger RM, Brumberg DJ, McGuire WL, Shuck JM. Crowe JP Jr, et al. Surg Gynecol Obstet. 1991 Oct;173(4):273-8. Surg Gynecol Obstet. 1991. PMID: 1925896 Clinical Trial.

51

The optimal timing of mastectomy: low tide or high tide?

McGuire WL. McGuire WL. Ann Intern Med. 1991 Sep 1;115(5):401-3. doi: 10.7326/0003-4819-115-5-401. Ann Intern Med. 1991. PMID: 1863031 No abstract available.

52

Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors.

Fuqua SA, Hill SM, Chamness GC, Benedix MG, Greene GL, O'Malley BW, McGuire WL. Fuqua SA, et al. J Natl Cancer Inst. 1991 Aug 21;83(16):1157-60. doi: 10.1093/jnci/83.16.1157. J Natl Cancer Inst. 1991. PMID: 1679459

53

Hormones and breast cancer.

Sunderland MC, McGuire WL. Sunderland MC, et al. Trends Endocrinol Metab. 1991 Mar-Apr;2(2):72-6. doi: 10.1016/1043-2760(91)90044-n. Trends Endocrinol Metab. 1991. PMID: 18411169

54

Breast cancer prognostic factors: evaluation guidelines.

McGuire WL. McGuire WL. J Natl Cancer Inst. 1991 Feb 6;83(3):154-5. doi: 10.1093/jnci/83.3.154. J Natl Cancer Inst. 1991. PMID: 1988696 No abstract available.

55

Follow-up study of HER-2/neu amplification in primary breast cancer.

Clark GM, McGuire WL. Clark GM, et al. Cancer Res. 1991 Feb 1;51(3):944-8. Cancer Res. 1991. PMID: 1988136 Review.

56

Variant human breast tumor estrogen receptor with constitutive transcriptional activity.

Fuqua SA, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL. Fuqua SA, et al. Cancer Res. 1991 Jan 1;51(1):105-9. Cancer Res. 1991. PMID: 1988075

57

Oncogenes as clinical prognostic indicators.

Sunderland MC, McGuire WL. Sunderland MC, et al. Cancer Treat Res. 1991;53:3-22. doi: 10.1007/978-1-4615-3940-7_1. Cancer Treat Res. 1991. PMID: 1672084 Review. No abstract available.

58

Progesterone antagonists block the growth of experimental mammary tumors in G0/G1.

Michna H, Schneider M, Nishino Y, el Etreby MF, McGuire WL. Michna H, et al. Breast Cancer Res Treat. 1990 Dec;17(2):155-6. doi: 10.1007/BF01806296. Breast Cancer Res Treat. 1990. PMID: 2096993 No abstract available.

59

Prognostic indicators in invasive breast cancer.

Sunderland MC, McGuire WL. Sunderland MC, et al. Surg Clin North Am. 1990 Oct;70(5):989-1004. doi: 10.1016/s0039-6109(16)45226-6. Surg Clin North Am. 1990. PMID: 2218829 Review.

60

A simple polymerase chain reaction method for detection and cloning of low-abundance transcripts.

Fuqua SA, Fitzgerald SD, McGuire WL. Fuqua SA, et al. Biotechniques. 1990 Aug;9(2):206-11. Biotechniques. 1990. PMID: 1698071

61

HER-2/neu amplification predicts poor survival in node-positive breast cancer.

Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL. Borg A, et al. Cancer Res. 1990 Jul 15;50(14):4332-7. Cancer Res. 1990. PMID: 1973070

62

Estrogen receptor gene methylation in human breast tumors.

Falette NS, Fuqua SA, Chamness GC, Cheah MS, Greene GL, McGuire WL. Falette NS, et al. Cancer Res. 1990 Jul 1;50(13):3974-8. Cancer Res. 1990. PMID: 2354445

63

How to use prognostic factors in axillary node-negative breast cancer patients.

McGuire WL, Tandon AK, Allred DC, Chamness GC, Clark GM. McGuire WL, et al. J Natl Cancer Inst. 1990 Jun 20;82(12):1006-15. doi: 10.1093/jnci/82.12.1006. J Natl Cancer Inst. 1990. PMID: 2189998 Review. No abstract available.

64

Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer.

Tandon AK, Clark GM, Chamness GC, McGuire WL. Tandon AK, et al. Cancer Res. 1990 Jun 1;50(11):3317-21. Cancer Res. 1990. PMID: 2334924

65

Isolation and characterization of an adriamycin-resistant breast tumor cell line.

Schneider SL, Fuqua SA, Speeg KV, Tandon AK, McGuire WL. Schneider SL, et al. In Vitro Cell Dev Biol. 1990 Jun;26(6):621-8. doi: 10.1007/BF02624212. In Vitro Cell Dev Biol. 1990. PMID: 1972704

66

Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay.

Fuqua SA, Falette NF, McGuire WL. Fuqua SA, et al. J Natl Cancer Inst. 1990 May 16;82(10):858-61. doi: 10.1093/jnci/82.10.858. J Natl Cancer Inst. 1990. PMID: 2332903

67

Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors.

Merkel DE, McGuire WL. Merkel DE, et al. Cancer. 1990 Mar 1;65(5):1194-205. doi: 10.1002/1097-0142(19900301)65:5<1194::aid-cncr2820650528>3.0.co;2-m. Cancer. 1990. PMID: 2406011 Review.

68

Cathepsin D and prognosis in breast cancer.

Tandon AK, Clark GM, Chamness GC, Chirgwin JM, McGuire WL. Tandon AK, et al. N Engl J Med. 1990 Feb 1;322(5):297-302. doi: 10.1056/NEJM199002013220504. N Engl J Med. 1990. PMID: 2296271 Free article.

69

DNA flow cytometry and other prognostic factors in breast cancer.

McGuire WL. McGuire WL. Cancer Invest. 1990;8(2):245-6. doi: 10.3109/07357909009017570. Cancer Invest. 1990. PMID: 2400941 No abstract available.

70

P-glycoprotein and progesterone receptor in human breast cancer.

McGuire WL. McGuire WL. Cancer Cells. 1990 Jan;2(1):27-9. Cancer Cells. 1990. PMID: 1974809 Review. No abstract available.

71

Loss of heterozygosity in breast cancer: cause or effect?

McGuire WL, Naylor SL. McGuire WL, et al. J Natl Cancer Inst. 1989 Dec 6;81(23):1764-5. doi: 10.1093/jnci/81.23.1764. J Natl Cancer Inst. 1989. PMID: 2585523 No abstract available.

72

Colony-stimulating factors. A panel discussion.

McGuire WL, Gabrilove J, Moore MA, Rinehart J. McGuire WL, et al. Breast Cancer Res Treat. 1989 Nov;14(2):193-200. doi: 10.1007/BF01810735. Breast Cancer Res Treat. 1989. PMID: 2605346

73

Megestrol acetate in breast cancer--a panel discussion.

McGuire WL, Johnson PA, Muss HB, Osborne CK. McGuire WL, et al. Breast Cancer Res Treat. 1989 Oct;14(1):33-8. doi: 10.1007/BF01805973. Breast Cancer Res Treat. 1989. PMID: 2605342

74

Induction of the estrogen-regulated "24K" protein by heat shock.

Fuqua SA, Blum-Salingaros M, McGuire WL. Fuqua SA, et al. Cancer Res. 1989 Aug 1;49(15):4126-9. Cancer Res. 1989. PMID: 2743305

75

Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification.

Merkel DE, Fuqua SA, Tandon AK, Hill SM, Buzdar AU, McGuire WL. Merkel DE, et al. J Clin Oncol. 1989 Aug;7(8):1129-36. doi: 10.1200/JCO.1989.7.8.1129. J Clin Oncol. 1989. PMID: 2569033

76

HER-2/neu oncogene protein and prognosis in breast cancer.

Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL. Tandon AK, et al. J Clin Oncol. 1989 Aug;7(8):1120-8. doi: 10.1200/JCO.1989.7.8.1120. J Clin Oncol. 1989. PMID: 2569032

77

Treatment of stage III breast cancer. A panel discussion.

McGuire WL, Abeloff MD, Hortobagyi GN, Swain SM. McGuire WL, et al. Breast Cancer Res Treat. 1989 Jul;13(3):225-35. doi: 10.1007/BF02106572. Breast Cancer Res Treat. 1989. PMID: 2758112

78

New biologic prognostic factors in breast cancer.

Clark GM, McGuire WL. Clark GM, et al. Oncology (Williston Park). 1989 May;3(5):49-54; discussion 58, 61, 64. Oncology (Williston Park). 1989. PMID: 2578003 Review.

79

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.

Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL. Clark GM, et al. N Engl J Med. 1989 Mar 9;320(10):627-33. doi: 10.1056/NEJM198903093201003. N Engl J Med. 1989. PMID: 2918874

80

Adjuvant therapy in node-negative breast cancer. A panel discussion.

McGuire WL, Abeloff MD, Fisher B, Glick JH, Henderson IC, Osborne CK. McGuire WL, et al. Breast Cancer Res Treat. 1989 Mar;13(2):97-115. doi: 10.1007/BF01806522. Breast Cancer Res Treat. 1989. PMID: 2659105 Clinical Trial. No abstract available.

81

Chromosomal assignments of human 27-kDa heat shock protein gene family.

McGuire SE, Fuqua SA, Naylor SL, Helin-Davis DA, McGuire WL. McGuire SE, et al. Somat Cell Mol Genet. 1989 Mar;15(2):167-71. doi: 10.1007/BF01535078. Somat Cell Mol Genet. 1989. PMID: 2538929

82

Adjuvant therapy of node-negative breast cancer.

McGuire WL. McGuire WL. N Engl J Med. 1989 Feb 23;320(8):525-7. doi: 10.1056/NEJM198902233200811. N Engl J Med. 1989. PMID: 2915655 No abstract available.

83

Prognostic factors for recurrence and survival in axillary node-negative breast cancer.

McGuire WL, Clark GM. McGuire WL, et al. J Steroid Biochem. 1989;34(1-6):145-8. doi: 10.1016/0022-4731(89)90075-7. J Steroid Biochem. 1989. PMID: 2696843 Review.

84

Prognosis in breast cancer.

McGuire WL, Clark GM. McGuire WL, et al. Recent Results Cancer Res. 1989;115:170-4. doi: 10.1007/978-3-642-83337-3_24. Recent Results Cancer Res. 1989. PMID: 2696030 Review. No abstract available.

85

Prognostic factors in breast cancer.

Saez RA, McGuire WL, Clark GM. Saez RA, et al. Semin Surg Oncol. 1989;5(2):102-10. doi: 10.1002/ssu.2980050206. Semin Surg Oncol. 1989. PMID: 2657970 Review.

86

P-glycoprotein in breast cancer.

Merkel DE, Fuqua SA, McGuire WL. Merkel DE, et al. Cancer Treat Res. 1989;48:97-105. doi: 10.1007/978-1-4613-1601-5_7. Cancer Treat Res. 1989. PMID: 2577143 Review. No abstract available.

87

Laboratory aspects of multidrug resistance.

Fuqua SA, Merkel DE, McGuire WL. Fuqua SA, et al. Cancer Treat Res. 1989;42:45-59. doi: 10.1007/978-1-4613-1747-0_3. Cancer Treat Res. 1989. PMID: 2577107 Review. No abstract available.

88

Pain control in breast cancer. A panel discussion.

McGuire WL, Foley KM, Levy MH, Osborne CK. McGuire WL, et al. Breast Cancer Res Treat. 1989 Jan;13(1):5-15. doi: 10.1007/BF01806545. Breast Cancer Res Treat. 1989. PMID: 2565124 Review.

89

Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism.

Hill SM, Fuqua SA, Chamness GC, Greene GL, McGuire WL. Hill SM, et al. Cancer Res. 1989 Jan 1;49(1):145-8. Cancer Res. 1989. PMID: 2562795

90

Development of polyclonal and monoclonal antibodies to iodinated contrast media.

Siegle RL, McGuire WL, Peters JE. Siegle RL, et al. Acta Radiol. 1988 Nov-Dec;29(6):737-40. Acta Radiol. 1988. PMID: 3190951

91

The role of growth factors in breast cancer. A panel discussion.

McGuire WL, Dickson RB, Osborne CK, Salomon D. McGuire WL, et al. Breast Cancer Res Treat. 1988 Oct;12(2):159-66. doi: 10.1007/BF01805937. Breast Cancer Res Treat. 1988. PMID: 3242646 No abstract available.

92

Adjuvant therapy of node-negative breast cancer: another point of view.

McGuire WL. McGuire WL. J Natl Cancer Inst. 1988 Sep 7;80(13):1075-6. doi: 10.1093/jnci/80.13.1075. J Natl Cancer Inst. 1988. PMID: 3411619 No abstract available.

93

In vitro assays to predict drug sensitivity and drug resistance. A panel discussion.

McGuire WL, Kern DH, Von Hoff DD, Weisenthal LM. McGuire WL, et al. Breast Cancer Res Treat. 1988 Sep;12(1):7-21. doi: 10.1007/BF01805735. Breast Cancer Res Treat. 1988. PMID: 3196887 No abstract available.

94

Estrogen receptor versus nuclear grade as prognostic factors in axillary node negative breast cancer.

McGuire WL. McGuire WL. J Clin Oncol. 1988 Jul;6(7):1071-2. doi: 10.1200/JCO.1988.6.7.1071. J Clin Oncol. 1988. PMID: 3392560 No abstract available.

95

Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer.

Benner SE, Clark GM, McGuire WL. Benner SE, et al. Am J Med Sci. 1988 Jul;296(1):59-66. doi: 10.1097/00000441-198807000-00011. Am J Med Sci. 1988. PMID: 3044107 Review.

96

A cDNA for the estradiol-regulated 24K protein: control of mRNA levels in MCF-7 cells.

Moretti-Rojas I, Fuqua SA, Montgomery RA 3rd, McGuire WL. Moretti-Rojas I, et al. Breast Cancer Res Treat. 1988 May;11(2):155-63. doi: 10.1007/BF01805839. Breast Cancer Res Treat. 1988. PMID: 3401605

97

Autologous bone marrow transplantation in breast cancer. A panel discussion.

McGuire WL, Herzig RH, Lemaistre CF, Peters WP. McGuire WL, et al. Breast Cancer Res Treat. 1988 Apr;11(1):7-17. doi: 10.1007/BF01807553. Breast Cancer Res Treat. 1988. PMID: 3289635 No abstract available.

98

Steroid receptors and other prognostic factors in primary breast cancer.

Clark GM, McGuire WL. Clark GM, et al. Semin Oncol. 1988 Apr;15(2 Suppl 1):20-5. Semin Oncol. 1988. PMID: 3285482 Review.

99

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.

Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL. Dressler LG, et al. Cancer. 1988 Feb 1;61(3):420-7. doi: 10.1002/1097-0142(19880201)61:3<420::aid-cncr2820610303>3.0.co;2-0. Cancer. 1988. PMID: 3338012

100

A 46-kDa antigen associated with estrogen receptor in human breast cancer.

Díaz-Chico BN, Ogasawara Y, Chamness GC, Salman M, McGuire WL. Díaz-Chico BN, et al. J Steroid Biochem. 1988;30(1-6):315-20. doi: 10.1016/0022-4731(88)90114-8. J Steroid Biochem. 1988. PMID: 3386260

101

Human breast tumor imaging using 111In labeled monoclonal antibody: athymic mouse model.

Khaw BA, Bailes JS, Schneider SL, Lancaster J, Powers J, Strauss HW, Lasher JC, McGuire WL. Khaw BA, et al. Eur J Nucl Med. 1988;14(7-8):362-6. doi: 10.1007/BF00254385. Eur J Nucl Med. 1988. PMID: 3181185

102

Oncogenes and cancer prognosis.

Merkel DE, McGuire WL. Merkel DE, et al. Important Adv Oncol. 1988:103-17. Important Adv Oncol. 1988. PMID: 3042600 Review. No abstract available.

103

P-glycoprotein gene amplification or overexpression is not detected in clinical breast cancer specimens.

Merkel DE, Fuqua SA, Hill SM, McGuire WL. Merkel DE, et al. Prog Clin Biol Res. 1988;276:61-73. Prog Clin Biol Res. 1988. PMID: 2902641 No abstract available.

104

Oncogenes in clinical cancer--a panel discussion.

McGuire WL, Johnson BE, Seeger RC, Slamon DJ. McGuire WL, et al. Breast Cancer Res Treat. 1987 Dec;10(3):217-27. doi: 10.1007/BF01805759. Breast Cancer Res Treat. 1987. PMID: 2833962 No abstract available.

105

Chemotherapy drug resistance--a panel discussion.

McGuire WL, Fojo A, Goldie JH, Ozols R. McGuire WL, et al. Breast Cancer Res Treat. 1987 Nov;10(2):133-44. doi: 10.1007/BF01810576. Breast Cancer Res Treat. 1987. PMID: 2892548 Review.

106

Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry.

Dressler LG, Seamer L, Owens MA, Clark GM, McGuire WL. Dressler LG, et al. Cancer Res. 1987 Oct 15;47(20):5294-302. Cancer Res. 1987. PMID: 3652035

107

Prognostic factors for recurrence and survival in human breast cancer.

McGuire WL. McGuire WL. Breast Cancer Res Treat. 1987 Oct;10(1):5-9. doi: 10.1007/BF01806129. Breast Cancer Res Treat. 1987. PMID: 3689982

108

Recurrence patterns in a prospective study of patients with stage II breast cancer treated with endocrine-chemotherapy.

Crowe JP Jr, Gordon NH, Antunez AR, Hubay CA, Pearson OH, Marshall JS, McGuire WL. Crowe JP Jr, et al. Surgery. 1987 Oct;102(4):622-7. Surgery. 1987. PMID: 3310297 Clinical Trial.

109

Flow cytometry, cellular DNA content, and prognosis in human malignancy.

Merkel DE, Dressler LG, McGuire WL. Merkel DE, et al. J Clin Oncol. 1987 Oct;5(10):1690-703. doi: 10.1200/JCO.1987.5.10.1690. J Clin Oncol. 1987. PMID: 3309200 Review.

110

P-glycoprotein expression in human breast cancer cells.

Fuqua SA, Moretti-Rojas IM, Schneider SL, McGuire WL. Fuqua SA, et al. Cancer Res. 1987 Apr 15;47(8):2103-6. Cancer Res. 1987. PMID: 3828999

111

An immunotoxin cytotoxic for breast cancer cells in vitro.

LeMaistre CF, Edwards DP, Krolick KA, McGuire WL. LeMaistre CF, et al. Cancer Res. 1987 Feb 1;47(3):730-4. Cancer Res. 1987. PMID: 3492266

112

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Slamon DJ, et al. Science. 1987 Jan 9;235(4785):177-82. doi: 10.1126/science.3798106. Science. 1987. PMID: 3798106

113

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

Clark GM, Sledge GW Jr, Osborne CK, McGuire WL. Clark GM, et al. J Clin Oncol. 1987 Jan;5(1):55-61. doi: 10.1200/JCO.1987.5.1.55. J Clin Oncol. 1987. PMID: 3806159

114

Resistance to endocrine therapy. A panel discussion.

McGuire WL, Lippman ME, Osborne CK, Thompson EB. McGuire WL, et al. Breast Cancer Res Treat. 1987;9(3):165-73. doi: 10.1007/BF01806377. Breast Cancer Res Treat. 1987. PMID: 3663953 No abstract available.

115

Drug dosage intensity--a panel discussion.

McGuire WL, Goldie J, Hryniuk W, Tormey DC. McGuire WL, et al. Breast Cancer Res Treat. 1987;9(2):87-100. doi: 10.1007/BF01807361. Breast Cancer Res Treat. 1987. PMID: 3620720

116

Predicting recurrence and survival in breast cancer. A panel discussion.

McGuire WL, Clark GM, Fisher ER, Henderson IC. McGuire WL, et al. Breast Cancer Res Treat. 1987;9(1):27-38. doi: 10.1007/BF01806691. Breast Cancer Res Treat. 1987. PMID: 3593989 No abstract available.

117

A new marker of maturation in the cervix: the estrogen-regulated 24K protein.

Dressler LG, Ramzy I, Sledge GW, McGuire WL. Dressler LG, et al. Obstet Gynecol. 1986 Dec;68(6):825-31. Obstet Gynecol. 1986. PMID: 3537878

118

The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patients.

Crowe JP Jr, Gordon NH, Hubay CA, Pearson OH, Marshall JS, McGuire WL. Crowe JP Jr, et al. Surgery. 1986 Oct;100(4):599-605. Surgery. 1986. PMID: 3764686

119

Direct counting of tritium by dissolving Microelisa wells in scintillation fluid.

Tandon AK, Chamness GC, McGuire WL. Tandon AK, et al. J Immunol Methods. 1986 Sep 27;92(2):281-3. doi: 10.1016/0022-1759(86)90176-6. J Immunol Methods. 1986. PMID: 3760588

120

Role of progesterone receptors in breast cancer.

McGuire WL, Clark GM. McGuire WL, et al. CA Cancer J Clin. 1986 Sep-Oct;36(5):302-9. doi: 10.3322/canjclin.36.5.302. CA Cancer J Clin. 1986. PMID: 3093016 Free article. Clinical Trial.

121

Estrogen receptor in very small breast tumor specimens: a modified charcoal-gelatin assay.

Tandon AK, Chamness GC, McGuire WL. Tandon AK, et al. Cancer Res. 1986 Jul;46(7):3375-7. Cancer Res. 1986. PMID: 3708571

122

Progesterone receptor assays in low-protein cytosols: a modified charcoal-gelatin procedure.

Tandon AK, Chamness GC, McGuire WL. Tandon AK, et al. J Steroid Biochem. 1986 Jun;24(6):1135-40. doi: 10.1016/0022-4731(86)90374-2. J Steroid Biochem. 1986. PMID: 2426518

123

Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.

Edwards DP, Grzyb KT, Dressler LG, Mansel RE, Zava DT, Sledge GW Jr, McGuire WL. Edwards DP, et al. Cancer Res. 1986 Mar;46(3):1306-17. Cancer Res. 1986. PMID: 3510721

124

Role of steroid hormone receptors as prognostic factors in primary breast cancer.

McGuire WL, Clark GM, Dressler LG, Owens MA. McGuire WL, et al. NCI Monogr. 1986;(1):19-23. NCI Monogr. 1986. PMID: 3774012

125

An estrogen-regulated protein in normal and malignant endometrium.

McGuire WL, Dressler LG, Sledge GW Jr, Ramzy I, Ciocca DR. McGuire WL, et al. J Steroid Biochem. 1986 Jan;24(1):155-9. doi: 10.1016/0022-4731(86)90045-2. J Steroid Biochem. 1986. PMID: 3702402

126

Prognostic factors in primary breast cancer.

McGuire WL. McGuire WL. Cancer Surv. 1986;5(3):527-36. Cancer Surv. 1986. PMID: 3555781 Review.

127

Monoclonal antibody characterization of a tumor-associated breast cancer antigen.

Edwards DP, Dressler LG, Zava DT, McGuire WL. Edwards DP, et al. Prog Clin Biol Res. 1986;204:71-88. Prog Clin Biol Res. 1986. PMID: 2421350 No abstract available.

128

Adjuvant endocrine therapy, cytotoxic chemotherapy and immunotherapy in stage II breast cancer: 6-year result.

Hubay CA, Pearson OH, Manni A, Gordon NH, McGuire WL. Hubay CA, et al. J Steroid Biochem. 1985 Dec;23(6B):1147-50. doi: 10.1016/0022-4731(85)90034-2. J Steroid Biochem. 1985. PMID: 3912620 Clinical Trial.

129

Eight-year follow-up of adjuvant therapy for stage II breast cancer.

Hubay CA, Gordon NH, Pearson OH, Marshall JS, McGuire WL. Hubay CA, et al. World J Surg. 1985 Oct;9(5):738-49. doi: 10.1007/BF01655189. World J Surg. 1985. PMID: 3904231 Clinical Trial. No abstract available.

130

Immunological detection of Chinese hamster ovary cells expressing a multidrug resistance phenotype.

Lathan B, Edwards DP, Dressler LG, Von Hoff DD, McGuire WL. Lathan B, et al. Cancer Res. 1985 Oct;45(10):5064-9. Cancer Res. 1985. PMID: 2862990

131

Presence of an estrogen-regulated protein in endometrial cancer.

Sledge GW Jr, Ramzy I, Dressler LG, Dorr FA, Adams DJ, McGuire WL. Sledge GW Jr, et al. Obstet Gynecol. 1985 Sep;66(3):423-7. Obstet Gynecol. 1985. PMID: 3895080

132

Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients.

McGuire WL, Dressler LG. McGuire WL, et al. J Natl Cancer Inst. 1985 Sep;75(3):405-10. J Natl Cancer Inst. 1985. PMID: 3861896 No abstract available.

133

Immunologic detection of a protein homologous to chicken progesterone receptor B subunit.

Peleg S, Schrader WT, Edwards DP, McGuire WL, O'Malley BW. Peleg S, et al. J Biol Chem. 1985 Jul 15;260(14):8492-501. J Biol Chem. 1985. PMID: 2409088 Free article.

134

Quantitative enzyme-linked immunosorbent assay for the estrogen-regulated Mr 24,000 protein in human breast tumors: correlation with estrogen and progesterone receptors.

Adams DJ, McGuire WL. Adams DJ, et al. Cancer Res. 1985 Jun;45(6):2445-9. Cancer Res. 1985. PMID: 3886134

135

Breast cancer prognosis in a mixed Caucasian-Hispanic population.

Daly MB, Clark GM, McGuire WL. Daly MB, et al. J Natl Cancer Inst. 1985 Apr;74(4):753-7. J Natl Cancer Inst. 1985. PMID: 3857371

136

Role of progesterone receptors in breast cancer.

McGuire WL, Clark GM. McGuire WL, et al. Semin Oncol. 1985 Mar;12(1 Suppl 1):12-6. Semin Oncol. 1985. PMID: 3975645

137

Progestin therapy for breast cancer: a panel discussion.

McGuire WL, Cavalli F, Bonomi P, Alexieva-Figussch J. McGuire WL, et al. Breast Cancer Res Treat. 1985;6(3):213-20. doi: 10.1007/BF01806771. Breast Cancer Res Treat. 1985. PMID: 4092098

138

Optimal surgical approaches to the local management of early breast cancer. A panel discussion.

McGuire WL, Donegan WL, Fisher B, Hayward JL. McGuire WL, et al. Breast Cancer Res Treat. 1985;6(2):101-12. doi: 10.1007/BF02235741. Breast Cancer Res Treat. 1985. PMID: 4052637

139

Strategies to identify or prevent drug resistance in cancer. A panel discussion.

McGuire WL, Goldie JH, Salmon SE, Ling V. McGuire WL, et al. Breast Cancer Res Treat. 1985;5(3):257-68. doi: 10.1007/BF01806020. Breast Cancer Res Treat. 1985. PMID: 4027394 No abstract available.

140

Monoclonal antibodies, benign breast disease, and breast cancer. A panel discussion.

McGuire WL, Ceriani RL, Schlom J, Frankel AE. McGuire WL, et al. Breast Cancer Res Treat. 1985;6(1):37-47. doi: 10.1007/BF01806009. Breast Cancer Res Treat. 1985. PMID: 3902124

141

The presence of an estrogen-regulated protein detected by monoclonal antibody in abnormal human endometrium.

Ciocca DR, Puy LA, Edwards DP, Adams DJ, McGuire WL. Ciocca DR, et al. J Clin Endocrinol Metab. 1985 Jan;60(1):137-43. doi: 10.1210/jcem-60-1-137. J Clin Endocrinol Metab. 1985. PMID: 3880561

142

Impact of flow cytometry on predicting recurrence and survival in breast cancer patients.

McGuire Wl, Meyer JS, Barlogie B, Kute TE. McGuire Wl, et al. Breast Cancer Res Treat. 1985;5(2):117-28. doi: 10.1007/BF01805985. Breast Cancer Res Treat. 1985. PMID: 2410071 No abstract available.

143

Androgen receptors and antiandrogen therapy for laryngeal carcinoma.

Mattox DE, Von Hoff DD, McGuire WL. Mattox DE, et al. Arch Otolaryngol. 1984 Nov;110(11):721-4. doi: 10.1001/archotol.1984.00800370023005. Arch Otolaryngol. 1984. PMID: 6385937 Clinical Trial.

144

Molecular cloning of a cDNA for the chicken progesterone receptor B antigen.

Zarucki-Schulz T, Kulomaa MS, Headon DR, Weigel NL, Baez M, Edwards DP, McGuire WL, Schrader WT, O'Malley BW. Zarucki-Schulz T, et al. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6358-62. doi: 10.1073/pnas.81.20.6358. Proc Natl Acad Sci U S A. 1984. PMID: 6593705 Free PMC article.

145

Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.

Clark GM, Osborne CK, McGuire WL. Clark GM, et al. J Clin Oncol. 1984 Oct;2(10):1102-9. doi: 10.1200/JCO.1984.2.10.1102. J Clin Oncol. 1984. PMID: 6491696

146

Structural analysis of chicken oviduct progesterone receptor using monoclonal antibodies to the subunit B protein.

Edwards DP, Weigel NL, Schrader WT, O'Malley BW, McGuire WL. Edwards DP, et al. Biochemistry. 1984 Sep 11;23(19):4427-35. doi: 10.1021/bi00314a029. Biochemistry. 1984. PMID: 6207857

147

Multiple progesterone receptor assays in human breast cancer.

Gross GE, Clark GM, Chamness GC, McGuire WL. Gross GE, et al. Cancer Res. 1984 Feb;44(2):836-40. Cancer Res. 1984. PMID: 6692382

148

Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein.

Grose C, Edwards DP, Weigle KA, Friedrichs WE, McGuire WL. Grose C, et al. Virology. 1984 Jan 15;132(1):138-46. doi: 10.1016/0042-6822(84)90098-9. Virology. 1984. PMID: 6320530

149

The prognostic importance of estrogen receptor level for Stage I breast cancer patients.

Crowe JP, Gordon NH, Hubay CA, Pearson OH, Marshall JS, Mansour EG, Hermann RE, Jones JC, Flynn WJ, McGuire WL. Crowe JP, et al. Curr Surg. 1984 Jan-Feb;41(1):24-6. Curr Surg. 1984. PMID: 6697760 No abstract available.

150

Estrogen-induced 24K protein in MCF-7 breast cancer cells is localized in granules.

Ciocca DR, Adams DJ, Edwards DP, Bjercke RJ, McGuire WL. Ciocca DR, et al. Breast Cancer Res Treat. 1984;4(4):261-8. doi: 10.1007/BF01806037. Breast Cancer Res Treat. 1984. PMID: 6518292

151

Estrogen-regulated protein in human breast cancer.

McGuire WL, Adams DJ, Edwards DP. McGuire WL, et al. J Steroid Biochem. 1984 Jan;20(1):73-5. doi: 10.1016/0022-4731(84)90191-2. J Steroid Biochem. 1984. PMID: 6368988

152

Progesterone receptors and human breast cancer; 'Wassink lecture' presented at the 3rd EORTC Breast Cancer Working Conference.

McGuire WL, Clark GM. McGuire WL, et al. Eur J Cancer Clin Oncol. 1983 Dec;19(12):1681-5. doi: 10.1016/0277-5379(83)90152-9. Eur J Cancer Clin Oncol. 1983. PMID: 6686553 No abstract available.

153

The prognostic role of progesterone receptors in human breast cancer.

McGuire WL, Clark GM. McGuire WL, et al. Semin Oncol. 1983 Dec;10(4 Suppl 4):2-6. Semin Oncol. 1983. PMID: 6669985

154

Progesterone receptors as a prognostic factor in Stage II breast cancer.

Clark GM, McGuire WL, Hubay CA, Pearson OH, Marshall JS. Clark GM, et al. N Engl J Med. 1983 Dec 1;309(22):1343-7. doi: 10.1056/nejm198312013092240. N Engl J Med. 1983. PMID: 6633596 Clinical Trial.

155

Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies.

Adams DJ, Hajj H, Edwards DP, Bjercke RJ, McGuire WL. Adams DJ, et al. Cancer Res. 1983 Sep;43(9):4297-301. Cancer Res. 1983. PMID: 6871865

156

Evidence for modulation of a 24K protein in human endometrium during the menstrual cycle.

Ciocca DR, Asch RH, Adams DJ, McGuire WL. Ciocca DR, et al. J Clin Endocrinol Metab. 1983 Sep;57(3):496-9. doi: 10.1210/jcem-57-3-496. J Clin Endocrinol Metab. 1983. PMID: 6348061

157

Purification of an estrogen-regulated breast cancer protein by monoclonal antibody affinity chromatography.

Adams DJ, Hajj H, Bitar KG, Edwards DP, McGuire WL. Adams DJ, et al. Endocrinology. 1983 Jul;113(1):415-7. doi: 10.1210/endo-113-1-415. Endocrinology. 1983. PMID: 6861712

158

Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity.

Ciocca DR, Adams DJ, Bjercke RJ, Sledge GW Jr, Edwards DP, Chamness GC, McGuire WL. Ciocca DR, et al. J Histochem Cytochem. 1983 May;31(5):691-6. doi: 10.1177/31.5.6341459. J Histochem Cytochem. 1983. PMID: 6341459

159

Monoclonal antibodies against three major glycoproteins of varicella-zoster virus.

Grose C, Edwards DP, Friedrichs WE, Weigle KA, McGuire WL. Grose C, et al. Infect Immun. 1983 Apr;40(1):381-8. doi: 10.1128/iai.40.1.381-388.1983. Infect Immun. 1983. PMID: 6299963 Free PMC article.

160

Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells.

Ciocca DR, Adams DJ, Edwards DP, Bjercke RJ, McGuire WL. Ciocca DR, et al. Cancer Res. 1983 Mar;43(3):1204-10. Cancer Res. 1983. PMID: 6825091 No abstract available.

161

Multiple estrogen receptor assays in human breast cancer.

Hull DF 3rd, Clark GM, Osborne CK, Chamness GC, Knight WA 3rd, McGuire WL. Hull DF 3rd, et al. Cancer Res. 1983 Jan;43(1):413-6. Cancer Res. 1983. PMID: 6847780

162

Prognostic factors in primary breast cancer.

Clark GM, McGuire WL. Clark GM, et al. Breast Cancer Res Treat. 1983;3 Suppl:S69-72. doi: 10.1007/BF01855130. Breast Cancer Res Treat. 1983. PMID: 6689475

163

The importance of estrogen and progesterone receptor in primary breast cancer.

Clark GM, McGuire WL, Hubay CA, Pearson OH, Carter AC. Clark GM, et al. Prog Clin Biol Res. 1983;132E:183-90. Prog Clin Biol Res. 1983. PMID: 6647468 No abstract available.

164

Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year results.

Pearson OH, Hubay CA, Marshall JS, Gordon NH, McGuire WL, Mansour EG, Hermann RE, Jones JC, Flynn WJ, Eckert C. Pearson OH, et al. Breast Cancer Res Treat. 1983;3 Suppl:S61-8. doi: 10.1007/BF01855129. Breast Cancer Res Treat. 1983. PMID: 6367862 Clinical Trial.

165

Progesterone receptors and human breast cancer.

Clark GM, McGuire WL. Clark GM, et al. Breast Cancer Res Treat. 1983;3(2):157-63. doi: 10.1007/BF01803558. Breast Cancer Res Treat. 1983. PMID: 6351950 Review.

166

Steroid hormone receptors in human breast cancer.

Sledge GW Jr, McGuire WL. Sledge GW Jr, et al. Adv Cancer Res. 1983;38:61-75. doi: 10.1016/s0065-230x(08)60187-6. Adv Cancer Res. 1983. PMID: 6349291 Review. No abstract available.

167

Estrogen regulation of specific proteins as a mode of hormone action in human breast cancer.

Adams DJ, Edwards DP, McGuire WL. Adams DJ, et al. Biomembranes. 1983;11:389-414. Biomembranes. 1983. PMID: 6338951 Review. No abstract available.

168

Immunohistochemical detection of an estrogen-regulated protein by monoclonal antibodies.

Ciocca DR, Adams DJ, Bjercke RJ, Edwards DP, McGuire WL. Ciocca DR, et al. Cancer Res. 1982 Oct;42(10):4256-8. Cancer Res. 1982. PMID: 7049357

169

Estrogen action in human breast cancer (review).

Edwards DP, McGuire WL. Edwards DP, et al. Anticancer Res. 1982 Sep-Oct;2(5):297-308. Anticancer Res. 1982. PMID: 6762142 No abstract available.

170

Steroid hormone receptors and carcinoma of the breast.

McGuire WL, Osborne CK, Clark GM, Knight WA 3rd. McGuire WL, et al. Am J Physiol. 1982 Aug;243(2):E99-102. doi: 10.1152/ajpendo.1982.243.2.E99. Am J Physiol. 1982. PMID: 7114210

171

New strategies for investigating antiestrogen action in breast cancer.

McGuire WL. McGuire WL. Cancer Res. 1982 Aug;42(8 Suppl):3420s-3423s. Cancer Res. 1982. PMID: 6177403

172

Questions about histochemical methods for steroid receptors.

Chamness GC, McGuire WL. Chamness GC, et al. Arch Pathol Lab Med. 1982 Feb;106(2):53-4. Arch Pathol Lab Med. 1982. PMID: 6895825 No abstract available.

173

Estrogen receptor status as a prognostic indicator for stage I breast cancer patients.

Crowe JP, Hubay CA, Pearson OH, Marshall JS, Rosenblatt J, Mansour EG, Hermann RE, Jones JC, Flynn WJ, McGuire WL. Crowe JP, et al. Breast Cancer Res Treat. 1982;2(2):171-6. doi: 10.1007/BF01806453. Breast Cancer Res Treat. 1982. PMID: 7171837

174

Specific protein synthesis regulated by estrogen in human breast cancer.

Edwards DP, Adams DJ, McGuire WL. Edwards DP, et al. J Steroid Biochem. 1981 Dec;15:247-59. doi: 10.1016/0022-4731(81)90281-8. J Steroid Biochem. 1981. PMID: 7339251 No abstract available.

175

Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors.

Mercer WD, Edwards DP, Chamness GC, McGuire WL. Mercer WD, et al. Cancer Res. 1981 Nov;41(11 Pt 1):4644-52. Cancer Res. 1981. PMID: 7030480

176

Human sex hormones stimulate the growth and maturation of Coccidioides immitis.

Drutz DJ, Huppert M, Sun SH, McGuire WL. Drutz DJ, et al. Infect Immun. 1981 May;32(2):897-907. doi: 10.1128/iai.32.2.897-907.1981. Infect Immun. 1981. PMID: 7251153 Free PMC article.

177

Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells.

Horwitz KB, Aiginger P, Kuttenn F, McGuire WL. Horwitz KB, et al. Endocrinology. 1981 May;108(5):1703-9. doi: 10.1210/endo-108-5-1703. Endocrinology. 1981. PMID: 7194178 No abstract available.

178

Monoclonal antibodies against ovalbumin.

Bjercke RJ, Hale PM, Mercer WD, McGuire WL. Bjercke RJ, et al. Biochem Biophys Res Commun. 1981 Mar 31;99(2):550-6. doi: 10.1016/0006-291x(81)91780-0. Biochem Biophys Res Commun. 1981. PMID: 7236283 No abstract available.

179

Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7).

Edwards DP, Adams DJ, McGuire WL. Edwards DP, et al. Breast Cancer Res Treat. 1981;1(3):209-23. doi: 10.1007/BF01806261. Breast Cancer Res Treat. 1981. PMID: 7348573 No abstract available.

180

Adjuvant therapy for stage II, estrogen receptor negative breast cancer.

Knight WA 3rd, Clark GM, Osborne CK, McGuire WL. Knight WA 3rd, et al. Breast Cancer Res Treat. 1981;1(2):131-4. doi: 10.1007/BF01805866. Breast Cancer Res Treat. 1981. PMID: 7348569

181

Correlation of primary breast cancer histopathology and estrogen receptor content.

Fisher ER, Osborne CK, McGuire WL, Redmond C, Knight WA 3rd, Fisher B, Bannayan G, Walder A, Gregory EJ, Jacobsen A, Queen DM, Bennett DE, Ford HC. Fisher ER, et al. Breast Cancer Res Treat. 1981;1(1):37-41. doi: 10.1007/BF01807890. Breast Cancer Res Treat. 1981. PMID: 7348564

182

Estrogen receptor measurement in low-protein breast cancer cytosols. A modified charcoal technique.

Powell BL, De La Garza M, Clark GM, McGuire WL. Powell BL, et al. Breast Cancer Res Treat. 1981;1(1):33-5. doi: 10.1007/BF01807889. Breast Cancer Res Treat. 1981. PMID: 7348563

183

Estrogen receptor, a marker for human breast cancer differentiation and patient prognosis.

Osborne CK, Fisher E, Redmond C, Knight WA, Yochmowitz MG, McGuire WL. Osborne CK, et al. Adv Exp Med Biol. 1981;138:377-85. doi: 10.1007/978-1-4615-7192-6_23. Adv Exp Med Biol. 1981. PMID: 7342719 No abstract available.

184

Estrogen regulation of growth and specific protein synthesis in human breast cancer cells in tissue culture.

Edwards DP, Adams DJ, McGuire WL. Edwards DP, et al. Adv Exp Med Biol. 1981;138:133-49. doi: 10.1007/978-1-4615-7192-6_8. Adv Exp Med Biol. 1981. PMID: 7342712

185

Adjuvant therapy of stage II breast cancer: 48-month follow-up of a prospective randomized clinical trial.

Hubay CA, Pearson OH, Marshall JS, Stellato TA, Rhodes RS, DeBanne SM, Rosenblatt J, Mansour EG, Hermann RE, Jones JC, Flynn WJ, Eckert C, McGuire WL. Hubay CA, et al. Breast Cancer Res Treat. 1981;1(1):77-82. doi: 10.1007/BF01807895. Breast Cancer Res Treat. 1981. PMID: 6756509 Clinical Trial.

186

Estrogen regulation of specific messinger RNA's in human breast cancer cells.

Adams DJ, Edwards DP, McGuire WL. Adams DJ, et al. Biochem Biophys Res Commun. 1980 Dec 31;97(4):1354-61. doi: 10.1016/s0006-291x(80)80016-7. Biochem Biophys Res Commun. 1980. PMID: 7213361 No abstract available.

187

The value of estrogen and progesterone receptors in the treatment of breast cancer.

Osborne CK, Yochmowitz MG, Knight WA 3rd, McGuire WL. Osborne CK, et al. Cancer. 1980 Dec 15;46(12 Suppl):2884-8. doi: 10.1002/1097-0142(19801215)46:12+<2884::aid-cncr2820461429>3.0.co;2-u. Cancer. 1980. PMID: 7448733

188

Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trial.

Hubay CA, Pearson OH, Marshall JS, Rhodes RS, DeBanne SM, Rosenblatt J, Mansour EG, Hermann RE, Jones JC, Flynn WJ, Eckert C, McGuire WL. Hubay CA, et al. Cancer. 1980 Dec 15;46(12 Suppl):2805-8. doi: 10.1002/1097-0142(19801215)46:12+<2805::aid-cncr2820461413>3.0.co;2-h. Cancer. 1980. PMID: 7004624 Clinical Trial.

189

Modern approaches to the treatment of breast cancer.

Osborne CK, Knight WA 3rd, Yochmowitz MG, McGuire WL. Osborne CK, et al. Blood. 1980 Nov;56(5):745-52. Blood. 1980. PMID: 7426746 Free article.

190

Nuclear estrogen receptors. Effect of inhibitors on processing and steady state levels.

Horwitz KB, McGuire WL. Horwitz KB, et al. J Biol Chem. 1980 Oct 25;255(20):9699-705. J Biol Chem. 1980. PMID: 6968750 Free article. No abstract available.

191

17 alpha-Estradiol is a biologically active estrogen in human breast cancer cells in tissue culture.

Edwards DP, McGuire WL. Edwards DP, et al. Endocrinology. 1980 Oct;107(4):884-91. doi: 10.1210/endo-107-4-884. Endocrinology. 1980. PMID: 7408775

192

Steroid hormone receptors in the management of human breast cancer.

Knight WA 3rd, Osborne CK, Yochmowitz MG, McGuire WL. Knight WA 3rd, et al. Ann Clin Res. 1980 Oct;12(5):202-7. Ann Clin Res. 1980. PMID: 7015982 Review.

193

Are histochemical methods for estrogen receptor valid?

Chamness GC, Mercer WD, McGuire WL. Chamness GC, et al. J Histochem Cytochem. 1980 Aug;28(8):792-8. doi: 10.1177/28.8.7003005. J Histochem Cytochem. 1980. PMID: 7003005

194

Hormone receptors in primary and advanced breast cancer.

Knight WA 3rd, Osborne CK, McGuire WL. Knight WA 3rd, et al. Clin Endocrinol Metab. 1980 Jul;9(2):361-8. doi: 10.1016/s0300-595x(80)80038-7. Clin Endocrinol Metab. 1980. PMID: 6249524 Review.

195

Subcellular compartmentalization of estrogen receptors in human breast cancer cells.

Edwards DP, Martin PM, Horwitz KB, Chamness GC, McGuire WL. Edwards DP, et al. Exp Cell Res. 1980 May;127(1):197-213. doi: 10.1016/0014-4827(80)90427-9. Exp Cell Res. 1980. PMID: 7379864 No abstract available.

196

Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer.

Edwards DP, Murthy SR, McGuire WL. Edwards DP, et al. Cancer Res. 1980 May;40(5):1722-6. Cancer Res. 1980. PMID: 7371001

197

Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary report.

Hubay CA, Pearson OH, Marshall JS, Rhodes RS, Debanne SM, Mansour EG, Hermann RE, Jones JC, Flynn WJ, Eckert C, McGuire WL. Hubay CA, et al. Surgery. 1980 May;87(5):494-501. Surgery. 1980. PMID: 7368100 Clinical Trial.

198

Estrogen induced synthesis of specific proteins in human breast cancer cells.

Edwards DP, Adams DJ, Savage N, McGuire WL. Edwards DP, et al. Biochem Biophys Res Commun. 1980 Apr 14;93(3):804-12. doi: 10.1016/0006-291x(80)91148-1. Biochem Biophys Res Commun. 1980. PMID: 7387677 No abstract available.

199

Steroid receptors and breast cancer.

McGuire WL. McGuire WL. Hosp Pract. 1980 Apr;15(4):83-8. doi: 10.1080/21548331.1980.11946586. Hosp Pract. 1980. PMID: 7399477

200

Clinical correlations of steroid receptors and male breast cancer.

Everson RB, Lippman ME, Thompson EB, McGuire WL, Wittliff JL, De Sombre ER, Jensen EV, Singhakowinta A, Brooks SC Jr, Neifeld JP. Everson RB, et al. Cancer Res. 1980 Apr;40(4):991-7. Cancer Res. 1980. PMID: 7357565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters